tamibarotene has been researched along with citric acid, anhydrous in 1 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (citric acid, anhydrous) | Trials (citric acid, anhydrous) | Recent Studies (post-2010) (citric acid, anhydrous) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 11,894 | 783 | 4,366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiu, K; Inoue, M; Katada, Y; Manabe, I; Nagai, R; Sasaki, M; Taguchi, T | 1 |
1 other study(ies) available for tamibarotene and citric acid, anhydrous
| Article | Year |
|---|---|
Poly-(L-lactic acid) and citric acid-crosslinked gelatin composite matrices as a drug-eluting stent coating material with endothelialization, antithrombogenic, and drug release properties.
Topics: Animals; Benzoates; Cell Proliferation; Citric Acid; Compomers; Cross-Linking Reagents; Delayed-Action Preparations; Drug-Eluting Stents; Endothelium, Vascular; Fibrinolytic Agents; Gelatin; Human Umbilical Vein Endothelial Cells; In Vitro Techniques; Lactic Acid; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Succinimides; Tetrahydronaphthalenes; Thrombosis | 2013 |